Skip to main content
logo
Ernexa Therapeutics Inc. (ERNA)
NASDAQ: ERNA · Real-Time Price · USD
12.14
+0.13 (1.08%)
At close: May 13, 2026, 4:00 PM EDT
12.01
-0.13 (-1.07%)
After-hours: May 13, 2026, 7:59 PM EDT

Ernexa Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
149151017217
Market Cap Growth
9.47%-37.62%55.01%-40.96%-92.39%3178.60%
Enterprise Value
5.377.8213.8641.85.95202.33
Last Close Price
12.1430.00110.25675.001207.5031275.00
PE Ratio
--0.54-0.09-0.44-0.40-1.47
PS Ratio
--25.96143.34--
PB Ratio
2.063.938.884.361.368.51
P/TBV Ratio
0.733.152.364.280.817.08
P/FCF Ratio
--1.34-0.93-0.48-0.78-9.18
P/OCF Ratio
--1.34-0.95-0.48-0.79-9.24
EV/Sales Ratio
--23.81614.71--
EV/EBITDA Ratio
--0.84-0.89-1.99-0.18-1.78
EV/EBIT Ratio
--0.84-0.88-1.98-0.18-1.78
EV/FCF Ratio
--1.11-0.86-2.05-0.28-8.56
Debt / Equity Ratio
0.030.120.2817.750.070.09
Debt / EBITDA Ratio
-0.03-0.05-0.04-1.99-0.04-0.02
Debt / FCF Ratio
-0.05-0.07-0.04-2.05-0.06-0.11
Net Debt / Equity Ratio
-1.28-0.58-0.6115.35-0.85-0.56
Net Debt / EBITDA Ratio
0.730.150.07-1.630.310.13
Net Debt / FCF Ratio
1.210.200.06-1.680.480.60
Asset Turnover
-00.020.0000
Quick Ratio
2.680.880.741.221.624.81
Current Ratio
2.891.010.801.461.795.10
Return on Equity (ROE)
-245.94%-686.69%-2264.31%-302.20%-130.71%-739.07%
Return on Assets (ROA)
-149.93%-168.40%-57.59%-59.20%-123.25%-511.68%
Return on Invested Capital (ROIC)
-4795.57%-682.63%-79.49%-95.68%-387.27%-1109.76%
Return on Capital Employed (ROCE)
-248.35%-368.92%-69.83%-73.92%-156.41%-604.49%
Earnings Yield
-80.55%-186.67%-1110.20%-226.85%-250.31%-67.88%
FCF Yield
-51.25%-74.85%-107.26%-209.57%-128.86%-10.89%
Buyback Yield / Dilution
-507.35%-593.08%-157.06%-74.04%-40.92%-146.19%
Total Shareholder Return
-507.35%-593.08%-157.06%-74.04%-40.92%-146.19%
Updated May 11, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q